Efficacy of sublingual immunotherapy (SLIT) in asthmatic patients with cedar pollen rhinoconjunctivitis

Efficacy of sublingual immunotherapy (SLIT) in asthmatic patients with cedar pollen rhinoconjunctivitis - Efficacy of SLIT in asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020445

Enrollment

Registered

2016-01-06

Start date

2016-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Asthmatic patients with cedar pollen rhinoconjunctivitis has a serum cedar pollen-specific IgE levels of at least Class 2 -Participant demonstrates understanding and has provided an appropriately signed and dated informed consent

Exclusion criteria

Exclusion criteria: -Malignancy -Infectious disease -Interstitial pneumonia -Administration of systemic corticosteroid -Is unlikely to cooperate with the requirements of the study including having the ability to communicate with the investigator appropriately.

Design outcomes

Primary

Measure	Time frame
symptom status of asthma	—

Countries

Japan

Contacts

Public ContactJun Ito

Juntendo University school of medicine Department of respiratory medicine

moisture@juntendo.ac.jp03-5802-1063

Outcome results